Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG) - Fig 2

<p><b>(A) Percentages of expanded NK (CD3^-) and T (CD3⁺) cells, indicated as percentages of CD16⁺, CD56⁺, CD54⁺ and siglec-7⁺ subpopulations. (B) Percentages of other expanded lymphoid subpopulations.</b> The study was done by flow cytometry. Values are expressed as % cells ± SD. The amount of 2B4+ cells was significantly lower (p = 0.016) in expanded activated patient lymphocytes.